18 December 2018
Cognitive dysfunction in Parkinson’s disease remains a significant, unmet therapeutic need for patients; as such it is vital that there is rigorous research into the topic. Here we will discuss six CANTAB tasks that can address this research gap.
5 December 2018
Normative data from linear and non-linear quantile regression in CANTAB: cognition in mid-to-late life in an epidemiological sample
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring recently published the first study to derive normative CANTAB data from quantile regressions of cognitive test performance for a large epidemiological sample of adults aged 57-84 years.
7 November 2018
1 November 2018
Dr Seán Haldane is a Consultant Neuropsychologist and expert witness who provides reports for defence lawyers, the Crown Prosecution Service and the police. We caught up with Dr Haldane to discuss how CANTAB Insight is integral to his work.
25 October 2018
We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.
24 October 2018
At CTAD 2018 we shared our new data on why a Bayesian approach is best to describe normative cognitive performance, especially when making scientifically robust comparisons to neurologically impaired groups.
16 October 2018
We caught up with University of Calgary Postdoctoral Research Fellows, Dr Matiram Pun and Dr Veronica Guadagni, to discuss the role of CANTAB in their recent research paper on how different exposures to high altitude affect cognitive function.